Martin Godbout
Founder at BioContact (Québec), Inc.
Profile
Martin Godbout is the founder of BioContact (Québec), Inc. (founded in 1994) and Genome Canada (founded in 2000).
He is currently a Director at Angiochem, Inc., Fonds Recherche sur Nature et les Technologies, Ataxia of Charlevoix-Saguenay Foundation, Montreal Invivo Organization, Fondation Sur Les Leucodystrophies, and Corporation Inno-centre du Québec.
He is also the President of Hodran Consultants, Inc. (since 2009).
Dr. Godbout has held former positions as Chairman of BioQuebec, Génome Québec, Inc., and Insitut de Recherche en Immunologie et en Cancérologie.
He was also a Director at Acasti Pharma, Inc. (2011), BioCapital Investment Advisors, Inc. (2003-2005), Mirati Therapeutics, Inc. (2002-2014), Asmacure Ltée, Conseil de la Science et de la Technologie du Québec (1996-2004), AmorChem Financial, Inc., and Senior Vice President at BioCapital Investment Advisors, Inc. He served as President & General Manager of Société Innovatech du Grand Montréal and holds the title of Principal at Order of Canada.
Dr. Godbout received his undergraduate degree from Université Laval in 1979 and holds a doctorate from the same institution.
Martin Godbout active positions
| Companies | Position | Start |
|---|---|---|
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Director/Board Member | - |
BioContact (Québec), Inc.
 BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services BioContact (Québec), Inc. operates a pharmaceutical partnership symposium. The company was founded by Martin Godbout and is headquartered in Quebec, Canada. | Founder | 2010-01-04 |
| Ataxia of Charlevoix-Saguenay Foundation | Director/Board Member | - |
| Hodran Consultants, Inc. | President | 2009-09-30 |
| Montreal Invivo Organization | Director/Board Member | - |
| Fonds Recherche sur Nature et les Technologies | Director/Board Member | - |
Fondation Sur Les Leucodystrophies
 Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Fondation Sur Les Leucodystrophies supports research in identifying the causes of leuko dystrophies. The company was founded by Marjolaine Verville and Eric Tailleur and is headquartered in Québec, Canada. | Director/Board Member | - |
Corporation Inno-centre du Québec
 Corporation Inno-centre du Québec Investment ManagersFinance Corporation Inno-centre du Québec provides advisory services. It specializes in business strategies, organization and marketing, financial strategy, trade agreements and intellectual property, and human resources. The company was founded by Claude Martel and Pierre Hugron and is headquartered in Montreal, Canada. | Director/Board Member | 2015-06-10 |
Former positions of Martin Godbout
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Chairman | 2013-07-22 |
| ░░░░░░ ░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░ ░░░░░░░ ░░ ░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░ ░░░░░░░░░░░░░ | ░░░░░░░░ | - |
Training of Martin Godbout
| Université Laval | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACASTI PHARMA INC. | Health Technology |
| Private companies | 19 |
|---|---|
BioCapital Investment Advisors, Inc.
 BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
| Société Innovatech du Grand Montréal | |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
BioContact (Québec), Inc.
BioContact (Québec), Inc. Medical/Nursing ServicesHealth Services BioContact (Québec), Inc. operates a pharmaceutical partnership symposium. The company was founded by Martin Godbout and is headquartered in Quebec, Canada. | Health Services |
| Conseil de la Science et de la Technologie du Québec | Government |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Health Technology |
| Ataxia of Charlevoix-Saguenay Foundation | |
| Hodran Consultants, Inc. | |
| Montreal Invivo Organization | |
| Fonds Recherche sur Nature et les Technologies | |
AmorChem Financial, Inc.
 AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | Finance |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Commercial Services |
Asmacure Ltée
 Asmacure Ltée Pharmaceuticals: MajorHealth Technology Asmacure Ltée develops novel, proprietary compounds that target cholinergic receptors for the treatment of inflammation, notably pulmonary airway diseases. The company was founded by Yvon Cormier and Evelyne Israel-Assayag in 2002 and is headquartered in Quebec, Canada. | Health Technology |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Commercial Services |
Fondation Sur Les Leucodystrophies
Fondation Sur Les Leucodystrophies Miscellaneous Commercial ServicesCommercial Services Fondation Sur Les Leucodystrophies supports research in identifying the causes of leuko dystrophies. The company was founded by Marjolaine Verville and Eric Tailleur and is headquartered in Québec, Canada. | Commercial Services |
Corporation Inno-centre du Québec
Corporation Inno-centre du Québec Investment ManagersFinance Corporation Inno-centre du Québec provides advisory services. It specializes in business strategies, organization and marketing, financial strategy, trade agreements and intellectual property, and human resources. The company was founded by Claude Martel and Pierre Hugron and is headquartered in Montreal, Canada. | Finance |
- Stock Market
- Insiders
- Martin Godbout
